Report Details

Report Name

Global API CDMO+CMC Service Platform Market Research Report 2024 Story

Pages

87

Price

$ 2900

Features

API CDMO+CMC Service Platform Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Lonza Group|||Catalent, Inc.|||Thermo Fisher Scientific|||Pfizer CentreOne|||CordenPharma International|||Boehringer Ingelheim BioXcellence|||Recipharm AB|||Changsha Jingyi Pharmaceutical Technology Co., Ltd.|||GlaxoSmithKline|||Samsung BioLogics|||Emergent BioSolutions            

Countries Covered

              United States|||Canada|||Germany|||France|||UK|||Italy|||Russia|||Nordic Countries|||China|||Japan|||South Korea|||Southeast Asia|||India|||Australia|||Mexico|||Brazil|||Turkey|||Saudi Arabia|||UAE            

Regions Covered

              North America|||Europe|||Asia-Pacific|||Latin America|||Middle East & Africa            

Prices

Single User License:

$ 2900

Multi User License:

$ 4350

Enterprise/Corporate User License:

$ 5800